Type 2 diabetes is the most common form of diabetes. It is caused by a lack of insulin in the body. This hormone is produced by the pancreas and releases it into the bloodstream. When glucose is absorbed into the cells, it serves as energy for the body’s organs and tissues. When the pancreas does not produce enough insulin, it is unable to respond to the glucose that is ingested. When this occurs, glucose in the blood remains in the bloodstream. As a result, the blood sugar level increases.
LIMITED TIME OFFER – Hurry Up!!!
Buy Now To Avail Flat 30% Off
Buy This Complete Business Report with Discounted Price @ https://www.coherentmarketinsights.com/insight/buy-now/1367
Global Diabetes Vaccine Market: Drivers
R&D of new products is expected to propel growth of the global diabetes vaccine market over the forecast period. For instance, in 2017, Massachusetts General Hospital Immunobiology Laboratory presented findings of clinical trial related to use of BCG vaccine to treat autoimmune response in type 1 diabetes, at 75th Scientific Sessions of the American Diabetes Association.
Moreover, high prevalence of diabetes is also expected to propel growth of the global diabetes vaccine market over the forecast period. For instance, according to the study, ‘Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)’, published by the American Diabetes Association, 500 million people worldwide suffered from type 2 diabetes in 2018.
Asia Pacific is expected to witness significant growth in the global diabetes vaccine market, owing to high prevalence of diabetes in the region. For instance, according to the National Diabetes and Diabetic Retinopathy Survey report published in October 2019, the prevalence of diabetes in India was 11.8% during 2015-2019 and the prevalence of known diabetes cases was 8.0% and new diabetes cases was 3.8% during the period.
North America is also expected to witness significant growth in the global diabetes vaccine market, owing to high prevalence of diabetes in the region. For instance, according to International Diabetes Federation’s IDF Diabetes Atlas 2019 Edition, the numbers of adults with diabetes in the U.S. was 31.0 million.
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1367
Global Diabetes Vaccine Market: Competitive Landscape
Major players operating in the global diabetes vaccine market include, Imcys and Diamyd Medical.
Global Diabetes Vaccine Market: Key Developments
Major players operating in the global diabetes vaccine market are focused on R&D to expand their product portfolio. For instance, in 2018, Imcys announced to commence its clinical trial for new diabetes vaccine that uses modified peptides called imotopes, which spurs specific type of immune cell to kill immune cells that work on the insulin producing beta cells, to treat type 1 diabetes.
Global Diabetes Vaccine Market: Segmentation
On the basis of age group, the global diabetes vaccine market is segmented into:
- Up to 20 Years of Age
- 20 Years and above
On the basis of end user, the global diabetes vaccine market is segmented into:
Reasons to Purchase This Report
• Current and future of Diabetes Vaccine Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Diabetes Vaccine Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Diabetes Vaccine Industry Impact
Chapter 2 Global Diabetes Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Diabetes Vaccine (Volume and Value) by Type
2.3 Global Diabetes Vaccine (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Diabetes Vaccine Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Diabetes Vaccine Market Analysis
Chapter 6 East Asia Diabetes Vaccine Market Analysis
Chapter 7 Europe Diabetes Vaccine Market Analysis
Chapter 8 South Asia Diabetes Vaccine Market Analysis
Chapter 9 Southeast Asia Diabetes Vaccine Market Analysis
Chapter 10 Middle East Diabetes Vaccine Market Analysis
Chapter 11 Africa Diabetes Vaccine Market Analysis
Chapter 12 Oceania Diabetes Vaccine Market Analysis
Chapter 13 South America Diabetes Vaccine Market Analysis
Chapter 14 Company Profiles and Key Figures in Diabetes Vaccine Business
Chapter 15 Global Diabetes Vaccine Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027